Início/Ações/LXRX

LXRX

USD

Lexicon Pharmaceuticals Inc. Common Stock

$1.340+0.010 (0.752%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$1.330

Máximo

$1.390

Mínimo

$1.325

Volume

2.72M

Fundamentos da empresa

Capitalização de mercado

487.0M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

2.36M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.28Atual $1.340Máximo $1.66

Notícias relacionadas

4/11/2025 · 13:30

GlobeNewswire

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two

Ver mais

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

30/10/2025 · 12:30

GlobeNewswire

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior

Ver mais